Galvanize Therapeutics Stock

galvanizetx.com/Healthcare / BioTech & PharmaFounded: 2022

Galvanize Therapeutics, headquartered in San Carlos, California, is a biomedical platform company that serves leading life-changing solutions utilizing engineering, biology, and healthcare delivery to patients and healthcare organizations. Galvanize Therapeutics created Pulsed Electric Field technologies that enable cell targeting for disease processes, that treat in ways unparalleled to other devices or drugs.

Register To Buy and Sell Shares

For more details on financing and valuation for Galvanize Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Galvanize Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Galvanize Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Galvanize Therapeutics investors also invested in these private companies

Team

Management Team

Jonathan Waldstreicher, MD
Founder and Chief Executive Officer
Kevin Taylor
Chief Operating Officer
Deb Sheffield
Senior Vice President, Regulatory and Quality Affiars
James Stambaugh
Senior Vice President, Clinical Affairs
William S. Krimsky, MD, FCCP, DAABIP
Chief Medical Officer
Bill Green
Senior Vice President, Sales and Marketing Oncology
Michael Iversen
Vice President, Business Development and Commercial Strategy
Steve Ricottone
Vice President, Global Market Development

Board Members

Doug Godshall, CHAIR
President and CEO, Shockwave Medical
Anna Batarina, CFA
Partner, ATP
Seth Harrison, MD
Founder and Managing Partner, ATP
Mohit Trikha, PhD
Venture Partner, ATP

Frequently Asked Questions About Galvanize Therapeutics’ Stock

plusminus
Can you buy Galvanize Therapeutics’ stock?
Galvanize Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Galvanize Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Galvanize Therapeutics’ stock?
Yes, you can sell stock of a private company like Galvanize Therapeutics. Forge can help you sell your Galvanize Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Galvanize Therapeutics’ stock price?
Galvanize Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Galvanize Therapeutics’ private market stock price with Forge Data.
plusminus
What is Galvanize Therapeutics’ stock ticker symbol?
Galvanize Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

With $100M, Galvanize Absorbs Two Biotechs to Advance Electric Pulse Therapies | BioSpace
Gala Therapeutics and Galaxy Medical will be folded into Galvanize Therapeutics to continue to develop their electric pulse therapies for bronchitis, cardiac arrhythmias and solid tumors.
Updated on: Apr 17, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.